X-101269222-C-T

Variant summary

Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_001168474.2(TAF7L):​c.1102G>A​(p.Glu368Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000597 in 1,206,197 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 22 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.00023 ( 0 hom., 7 hem., cov: 23)
Exomes 𝑓: 0.000042 ( 0 hom. 15 hem. )

Consequence

TAF7L
NM_001168474.2 missense

Scores

3
14

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.07
Variant links:
Genes affected
TAF7L (HGNC:11548): (TATA-box binding protein associated factor 7 like) This gene is similar to a mouse gene that encodes a TATA box binding protein-associated factor, and shows testis-specific expression. The encoded protein could be a spermatogenesis-specific component of the DNA-binding general transcription factor complex TFIID. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -8 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.042416096).
BS2
High Hemizygotes in GnomAd4 at 7 gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
TAF7LNM_001168474.2 linkc.1102G>A p.Glu368Lys missense_variant 13/13 ENST00000356784.2 NP_001161946.1 Q5H9L4-2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
TAF7LENST00000356784.2 linkc.1102G>A p.Glu368Lys missense_variant 13/131 NM_001168474.2 ENSP00000349235.1 Q5H9L4-2
TAF7LENST00000372907.7 linkc.1360G>A p.Glu454Lys missense_variant 13/131 ENSP00000361998.3 Q5H9L4-1
TAF7LENST00000324762.10 linkc.880G>A p.Glu294Lys missense_variant 11/112 ENSP00000320283.6 Q5H9L4-3

Frequencies

GnomAD3 genomes
AF:
0.000232
AC:
26
AN:
112017
Hom.:
0
Cov.:
23
AF XY:
0.000205
AC XY:
7
AN XY:
34199
show subpopulations
Gnomad AFR
AF:
0.000843
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000551
AC:
10
AN:
181516
Hom.:
0
AF XY:
0.0000454
AC XY:
3
AN XY:
66108
show subpopulations
Gnomad AFR exome
AF:
0.000688
Gnomad AMR exome
AF:
0.0000370
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000420
AC:
46
AN:
1094180
Hom.:
0
Cov.:
28
AF XY:
0.0000417
AC XY:
15
AN XY:
359762
show subpopulations
Gnomad4 AFR exome
AF:
0.00133
Gnomad4 AMR exome
AF:
0.0000285
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000188
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.000152
GnomAD4 genome
AF:
0.000232
AC:
26
AN:
112017
Hom.:
0
Cov.:
23
AF XY:
0.000205
AC XY:
7
AN XY:
34199
show subpopulations
Gnomad4 AFR
AF:
0.000843
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000142
Hom.:
0
Bravo
AF:
0.000268
ESP6500AA
AF:
0.000782
AC:
3
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.0000494
AC:
6

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsJul 26, 2023The c.1360G>A (p.E454K) alteration is located in exon 13 (coding exon 13) of the TAF7L gene. This alteration results from a G to A substitution at nucleotide position 1360, causing the glutamic acid (E) at amino acid position 454 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.075
BayesDel_addAF
Benign
-0.62
T
BayesDel_noAF
Benign
-0.75
CADD
Benign
5.8
DANN
Uncertain
0.99
DEOGEN2
Benign
0.15
T;.;.
FATHMM_MKL
Uncertain
0.78
D
LIST_S2
Benign
0.75
T;T;T
M_CAP
Benign
0.022
T
MetaRNN
Benign
0.042
T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Uncertain
2.3
M;.;.
PrimateAI
Benign
0.40
T
PROVEAN
Benign
-2.0
N;N;N
REVEL
Benign
0.048
Sift
Benign
0.12
T;T;T
Sift4G
Benign
0.095
T;T;T
Polyphen
0.096
B;B;.
Vest4
0.14
MVP
0.13
MPC
0.31
ClinPred
0.023
T
GERP RS
1.6
Varity_R
0.086
gMVP
0.042

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs371321321; hg19: chrX-100524210; API